Docstoc

CU_PHARMA_CEUTICS_STAFFDATA_Mohamed_El-Miligi

Document Sample
CU_PHARMA_CEUTICS_STAFFDATA_Mohamed_El-Miligi Powered By Docstoc
					                                Mohamed Farid El-Miligi


    Title Professor of Pharmaceutics, Pharmaceutics and Industrial Pharmacy, Department                     Photo
  E-mail drmiligi@hotmail.com , drmiligi@gmail.com, drmiligi@yahoo.com, mspharm@idsc.net.eg,
           mmiligi@must.edu.eg
  Phone    02-23632245 / 02-23639307 / 02-2567457 / 02-23624917

Education
  Most Recent Degree Ph. D.
          Title of Thesis The Use of Masticating Materials as Basics for Pharmaceuticals

         Specialization Pharmaceutics and Industrial Pharmacy
   University Attended Cairo University
                   Year 1972
Experience
 A. Teaching Experience
                                  Course Title               Course       University          Academic years
                                                              Code
                                                                                              th
 Undergraduate           Industrial Pharmacy                             Cairo University   4 year
 Courses
 Postgraduate             Computer and its Applications      2001                          Diploma of Industrial
 Courses                  Information Technology                                           Pharmacy



 B. Professional Experience
    1. Dean of Faculty of Pharmacy, Misr University for Science and Technology.
    2.   Professor of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University
    3. Professor of Pharmaceutics and Industrial Pharmacy Department, College of Pharmacy, Misr University
          for Science & Technology (MUST)
    4.   Established and Directed the Computer Center of Faculty of Pharmacy from 1987 till October 2002.
    5.   Established and Directed the Open Learning Center of Cairo University from 1990 till 1994.

Publications and Presentations
    1.   Patent No. 8703, Category No. 6/8 (20th July 1966), Egypt: An Artificial Mouth for Mastication, used for
         assaying and evaluating materials and medicaments that may be orally administered.
    2.   Construction and Standardization of a Chewing Apparatus for Examining Medicated Chewing Gum; co-
         authored with A. A. Kassem. Read before the 12th Pan Arabian Pharmaceutical Conference in Algeria
     (1970).
3.   Preparation and Formulation of Suitable Masticates of Vitamin "C" from-Different Chewing-Gum Bases;
     co-authored with A. A. Kassem. Read before the 12th Pan Arabian Pharmaceutical Conference in Algeria
     (1970).
4.   Preparation and Formulation of Suitable Antacid Masticates; co authored with A. A. Kassem. Read before
     the 12th Pan Arabian Pharmaceutical Conference in Algeria (1970).
5.   Preparation and Formulation of Suitable Masticates of Aspirin; co authored with A. A. Kassem. Read
     before the 12th Pan Arabian Pharmaceutical Conference in Algeria (1970).
6.   Effect of Chewing-Gum Bases on the Rate of Release of Medicaments from Masticates; co-authored with
     A. A. Kassem and S.A. Zaki. Accepted for publication in the Bulletin of the Faculty of Pharmacy, Cairo
     University, Egypt.
7.   Effect of Drug Concentration in Masticates on its Rate of Release; ibid.
8.   Effect of Drug Solubility on its Rate of Release from Masticates, co authored with A. A. Kassem and Prof.
     S. A. Zaki. Bull. Fac. Pharm., Cairo Univ., Vol. XII, No. 2, pp. 1-10 (1973).
9.   Effect of Small Dose and Low Solubility of a Drug on its Rate of Release from Masticates; co-authored
     with A. A. Kassem and S.A. Zaki. Accepted for publication in the Bull. Fac. Pharm., Cairo Univ., Egypt.
10. Stability of Aspirin in Masticates; Part I: Direct Acidimetrical Assay for the Stability of Aspirin; ibid.
11. Stability of Aspirin in Masticates; Part II: Investigation of the Stability of Aspirin; ibid.
12. Stability of Aspirin in Masticates; Part IIl: Preparation of Stable Masticates of Aspirin; ibid.
13. Stability of Vitamin "C" in Masticates; co-authored with A. A. Kassem and S. A. Zaki. Bull. Fac. Pharm.,
     Cairo Univ., Vol. XII, No. 2, pp. 65-75 (1973).
14. Stability of Nystatin Ointment; co-authored with A. A. Kassem, Jr. Bull. Fac. Pharm., Cairo Univ., Vol. XV,
     No.1, pp. 67-79 (1976).
15. Stability of Nystatin in Different Unstabilized Suspensions; co authored with A. A. Kassem, Jr. Bull. Fac.
     Pharm., Cairo Univ., Egypt, Vol. 27, No.3, pp. 49-52 (1989).
16. A Photographic Approach for the Determination of the Angle of Repose; single-authored. Bull. Fac.
     Pharm., Cairo Univ., Egypt, Vol. 27, No.2, pp. 39 42 (1989).
17. Chemical Stability of Ferrous Fumarate Tablets; co-authored with E. Nour-El-Din and M. A. Kassem. Bull.
     Fac. Pharm., Cairo Univ., Egypt, Vol. 27, No.2, pp. 43-46 (1989).
18. Influence of Manufacturing Technique on the Chemical Stability of L Ascorbic Acid in Compressed Tablets;
     co-authored with A. A. Kassem, E. Nour-El-Din, A. Sakr, S. A. Said, and M. A. Kassem. Bull. Fac. Pharm.,
     Cairo Univ., Egypt, Vol. 27, No.3, pp. 40-44 (1989).
19. The Use of Carbopol Resins As Suspending Agents for Antacid Suspension; co-authored with A. A. Kassem
     Jr. J. Drug Res., Egypt, Vol. 10, No. 1-2, pp.103-117 (1978).
20. Formulation of Sulphaphenazole Suspension; co-authored with A. A. Kassem Jr. J. Drug Res., Egypt, Vol.
     10, No. 1-2, pp. 13-23 (1978).
21. An Approach Towards the Determination of the Order of Decomposition Reactions of Certain
    Medicaments in Tablet Formulations; co-authored with E. Nour-El-Din and M. A. Kassem. Bull. Fac.
    Pharm., Cairo Univ., Egypt, Vol. 27, No.1, pp. 20-23 (1989).
22. Chemical Stability of Acetylsalicylic Acid in Tablets; ibid. Bull. Fac. Pharm., Cairo Univ., Egypt, Vol. 27,
    No.3, pp. 29-32 (1989).
23. Chemical Stability of Ferrous Sulphate Tablets; ibid. Bull. Fac. Pharm., Cairo Univ., Egypt, Vol. 27, No.2,
    pp. 47-50 (1989).
24. Formulation and Evaluation of Controlled-Dissolution Potassium Chloride Macromolecular Powdered-
    Block Products Employing In-Situ Solution Polymerization Technique with methyl-methacrylate; co
    authored with A. A. Kassem, M. S. A. El-Samaligy and Hanaa A. Mahmoud. Accepted for publication in the
    J. Drug. Res., Egypt.
25. Formulation and Evaluation of Controlled-Dissolution Potassium Chloride Macromolecular Granular
    Microcapsules By In-Situ Polymerization; ibid.
26. Formulation and Evaluation of Controlled-Dissolution Phenobarbitone Macromolecular Products
    Employing In-Situ Suspension-Polymerization with Methylmethacrylate; ibid. Accepted for publication in
    the J. Pharm. Sci., Egypt.
27. Formulation and Evaluation of Phenobarbitone Macromolecular Solid Dispersions; ibid.
28. Experimental Evaluation Heptaminol; co-authored with A. A. Kassem and Siham A. Ali. Bull. Fac. Pharm.,
    Cairo Univ., Egypt, Vol. XX, No. 1 (1981).
29. Formulation and Characterization of Heptaminol Compressed Tablets; ibid. Bull. Fac. Pharm., Cairo Univ.,
    Egypt, Vol. 27, No.3, pp. 36-39 (1989).
30. Chemical Stability of Heptaminol Tablets; ibid. Bull. Fac. Pharm., Cairo Univ., Egypt, Vol. 27, No.3, pp. 33-
    35 (1989).
31. Formulation and Stability of Heptaminol Injectable Solution; ibid.
32. Formulation and Stability of Heptaminol Drops; ibid.
33. Formulation and Stability of Heptaminol Suppositories; ibid. Bull. Pharm. Sci., Assiut University, Vol. 7,
    Part 1: pp. 122-142 (1984).
34. Application of In-Situ Solution Polymerization of Methylmethacrylate for the Preparation of Granular
    Microcapsules (GM); co-authored with A. A. Kassem, Peter Rohdewald, M. S. A. EI-Samaligy, and Hanaa A.
    Mahmoud. Bull. Fac. Pharm., Cairo Univ., Vol. XXI, No. 1, pp. 231-245 (1982).
35. Application of In-Situ Interfacial Polymerization of Polyamide Components for the Preparation of
    Hydrochlorothiazide Spherical; (Part I): Preliminary Investigations on the General Formula for the
    Preparation of Hydrochlorothiazide (SM) by In-Situ Interfacial Polymerization of Polyamide Components;
    ibid. Bull. Fac. Pharm., Cairo Univ., Egypt, Vol. 27, No.3, pp. 19-22 (1989).
36. Application of In-Situ Interfacial Polymerization of Polyamide Components for the Preparation of
    Hydrochlorothiazide Spherical; (Part II): Influence of Some Aqueous Phase Modifiers; ibid. Bull. Fac.
    Pharm., Cairo Univ., Egypt, Vol. 27, No.3, pp. 23-27 (1989).
37. Application   of    In-Situ   Bead-Matrix    Polymerization    of   Acrylamide   for   the   preparation   of
    Hydrochlorothiazide, Micro-Beads. Bull. Fac. Pharm., Cairo Univ., Vol. XXI, No. 1(1982).
38. Bioavailability and Pharmacokinetic Evaluation of Hydrochlorothiazide Products Prepared by In-Situ
    Polymerization Techniques. Read before the 18th Egyptian Pharmaceutical Conference in Cairo, Egypt
    (1984).
39. Response of Mefenamic-Acid Solubility to Certain Chemical Adjuvants; co-authored with G. El-Mahrouk,
    A. A. Kassem Jr., and M. A. Kassem. Accepted for publication in the Bull. Fac. Pharm., Cairo Univ., Egypt.
40. Effect of Cosolvency on Mefenamic Acid; ibid.
41. A Contribution Towards the Determination of Cephradine in Pharmaceutical Formulations; co-authored
    with A. El-Assassy, M.A. Kassem, T. El-Kersh, and M. A. Ismail.           Read before the 18th Egyptian
    Pharmaceutical Conference in Cairo, Egypt (1984).
42. Pharmaceutical Aspects of Cephradine in Tablets; ibid. Bull. Fac. Pharm., Cairo Univ., Egypt, Vol. 27, No.3,
    pp. 72-76 (1989).
43. Pharmaceutical Aspects of Cephradine in Suppositories; ibid. Bull. Fac. Pharm., Cairo Univ., Egypt, Vol.
    27, No.1, pp. 72-76 (1989).
44. Enhancement of Dissolution Rate of Chlorpropamide by Solvent Deposition Techniques; co-authored with
    M. A. A. Kassem and S. Tayel. Bull. Fac. Pharm., Cairo Univ., Egypt, Vol. 27, No.1, pp. 56-61 (1989).
45. Formulation and Stability Study on Anhydrous Ampicillin and Penicillin Suspension For Reconstitution; co-
    authored with A. Abdel-Bary, A. M. Hashem, and S. H. El-Sherif. Az. J. Microbiol., Egypt, Vol. 27, pp. 162-
    173 (1995).
46. Rectal Absorption of Drugs - Indirect Characterization of the Rectal Membrane using the Bagley Diagram
    and In-Vivo Drug Absorption Data; co authored with Rüdiger Gröning, W. S. A. Sakran, M. S. Adel and A.
    Abdel-Bary. Eur. J. Pharm. Biopharm., 42 suppl., 55 (1996).
47. Improving the Solubility and Dissolution of Meloxicam by the Use of Solid Dispersions; co-authored with
    M. A. El-Nabarawi and S. A. Abdel-Halim. 20th Pharmaceutical Technology Conference CD, Liverpool, U.K.
    105 (2001).
48. Comparative Study on Aging Meloxicam Solid Dispersions with Meloxicam -b-cyclodextrin; co-authored
    with M. A. El-Nabarawi and S.A. Abdel-Halim. Az. J. Pharm. Sci., 29, 346 (2002).
49. Formulation, Evaluation, Bioavailability, and Clinical Evaluation of Rapid Saliva -Soluble Tablets of
    Meloxicam; co-authored with M. A. El Nabarawi; A.M. Kholief, and S.A. Abdel-Halim. Bull. Fac. Pharm.,
    Cairo University, Vol.41, 143 (2003)
50. Design, Characterization, and Clinical Evaluation of Meloxicam Dento Oral Gel; co-authored with M. A. El-
    Nabarawi; S. A. Abdel-Halim, A. E. Abdel Latif, and F. A. El-Shehaby. Bull. Fac. Pharm., Cairo University,
    Vol. 41, 33 (2003)
51. Patent No. 23217, (7/8/2004), Egypt, co-authored with M. A. El Nabarawi and S. A. Abdel-Halim: Method
    for the Preparation of Rapid Saliva Soluble Tablets of Meloxicam.
52. Patent No. 23218, (7/8/2004), Egypt, co-authored with M. A. El Nabarawi and S. A. Abdel-Halim: Method
    for the Preparation of Oral Gel of Meloxicam for the Treatment of Dento-Oral Inflammation.
   53. Melt Agglomeration of Allopurinol in Zanchetta High-Shear Mixer; co-authored with A. A. Badawi, W. S.
        Sakran, and K. A. Ibraheem. Egypt. J. Biomed. Sci., Vol. 24, July (2007).


Memberships
   1.   Sponsoring the "Drug Information Center" (DIC) at MUST
   2.   Associate member of the Pharmaceutical Consultancy Group "PHARMEX".
   3.   Member of the Arab Management Society

 Awards
   Sharja Excellence Award for Handicapped in the Arab World December 1998

				
DOCUMENT INFO